Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Boden

Showing results (31-40 of 53) with videos related to

Pageof 6
Sort By:
British Journal of Cancer|January 1, 1995
Galactosylated streptavidin for improved clearance of biotinylated intact and F(ab')2 fragments of an anti-tumour antibodyD Marshall, R B Pedley, R G Melton, et al.
British Journal of Cancer|March 1, 1996
Polyethylene glycol modification of a galactosylated streptavidin clearing agent: effects on immunogenicity and clearance of a biotinylated anti-tumour antibodyD Marshall, R B Pedley, J A Boden, et al.
International Journal of Cancer|February 20, 1991
The effect of radiosensitizers on radio-immunotherapy, using 131I-labelled anti-CEA antibodies in a human colonic xenograft modelR B Pedley, R H Begent, J A Boden, et al.
International Journal of Cancer|June 15, 1994
Enhancement of radioimmunotherapy by drugs modifying tumour blood flow in a colonic xenograft modelR B Pedley, R H Begent, J A Boden, et al.
Radiation Research|June 22, 2001
A mouse model for calculating the absorbed beta-particle dose from (131)I- and (90)Y-labeled immunoconjugates, including a method for dealing with heterogeneity in kidney and tumorA A Flynn, A J Green, R B Pedley, et al.
Cancer Biotherapy & Radiopharmaceuticals|January 5, 2002
Optimizing radioimmunotherapy by matching dose distribution with tumor structure using 3D reconstructions of serial imagesA A Flynn, R B Pedley, A J Green, et al.
Cancer Investigation|August 7, 2003
Higher dose and dose-rate in smaller tumors result in improved tumor controlA Mayer, E Tsiompanou, A A Flynn, et al.
Journal of Environmental Quality|November 13, 2004
Refined tunable methodology for characterization of contaminant-particle relationships in surface waterChristopher H Marvin, Gary G Leppard, M Marcia West, et al.
British Journal of Cancer|December 1, 1994
The potential for enhanced tumour localisation by poly(ethylene glycol) modification of anti-CEA antibodyR B Pedley, J A Boden, R Boden, et al.
Cancer Research|July 15, 1996
Ablation of colorectal xenografts with combined radioimmunotherapy and tumor blood flow-modifying agentsR B Pedley, J A Boden, R Boden, et al.
Pageof 6

Showing results (31-40 of 53) with videos related to

Sort By:
Pageof 6
British Journal of Cancer|January 1, 1995
Galactosylated streptavidin for improved clearance of biotinylated intact and F(ab')2 fragments of an anti-tumour antibodyD Marshall, R B Pedley, R G Melton, et al.
British Journal of Cancer|March 1, 1996
Polyethylene glycol modification of a galactosylated streptavidin clearing agent: effects on immunogenicity and clearance of a biotinylated anti-tumour antibodyD Marshall, R B Pedley, J A Boden, et al.
International Journal of Cancer|February 20, 1991
The effect of radiosensitizers on radio-immunotherapy, using 131I-labelled anti-CEA antibodies in a human colonic xenograft modelR B Pedley, R H Begent, J A Boden, et al.
International Journal of Cancer|June 15, 1994
Enhancement of radioimmunotherapy by drugs modifying tumour blood flow in a colonic xenograft modelR B Pedley, R H Begent, J A Boden, et al.
Radiation Research|June 22, 2001
A mouse model for calculating the absorbed beta-particle dose from (131)I- and (90)Y-labeled immunoconjugates, including a method for dealing with heterogeneity in kidney and tumorA A Flynn, A J Green, R B Pedley, et al.
Cancer Biotherapy & Radiopharmaceuticals|January 5, 2002
Optimizing radioimmunotherapy by matching dose distribution with tumor structure using 3D reconstructions of serial imagesA A Flynn, R B Pedley, A J Green, et al.
Cancer Investigation|August 7, 2003
Higher dose and dose-rate in smaller tumors result in improved tumor controlA Mayer, E Tsiompanou, A A Flynn, et al.
Journal of Environmental Quality|November 13, 2004
Refined tunable methodology for characterization of contaminant-particle relationships in surface waterChristopher H Marvin, Gary G Leppard, M Marcia West, et al.
British Journal of Cancer|December 1, 1994
The potential for enhanced tumour localisation by poly(ethylene glycol) modification of anti-CEA antibodyR B Pedley, J A Boden, R Boden, et al.
Cancer Research|July 15, 1996
Ablation of colorectal xenografts with combined radioimmunotherapy and tumor blood flow-modifying agentsR B Pedley, J A Boden, R Boden, et al.
Pageof 6